The TrkC antibody market will reach $2.56B by 2029 at 12.2% CAGR, driven by precision medicine, neuro-oncology research, biomarker diagnostics, and antibody innovations.
Read More
The viral vector affinity resin market will reach $1.13B by 2029 at 16% CAGR, driven by viral vector demand, clinical trials, advanced purification, and automation.
Read More
The vector embedding API market will reach $5.44B by 2029 at 30.4% CAGR, fueled by AI personalization, real-time search, semantic search, and cloud-native services.
Read More
The utility CIS software market will reach $3.15B by 2029 at 8.7% CAGR, driven by digital billing, AI customer tools, smart cities, and cloud-based platform integration.
Read More
The TrkC antibody market will reach $2.56B by 2029 at 12.2% CAGR, driven by precision medicine, neuro-oncology research, biomarker diagnostics, and antibody innovations.
Read More
The viral vector affinity resin market will reach $1.13B by 2029 at 16% CAGR, driven by viral vector demand, clinical trials, advanced purification, and automation.
Read More
The vector embedding API market will reach $5.44B by 2029 at 30.4% CAGR, fueled by AI personalization, real-time search, semantic search, and cloud-native services.
Read More
The utility CIS software market will reach $3.15B by 2029 at 8.7% CAGR, driven by digital billing, AI customer tools, smart cities, and cloud-based platform integration.
Read More
The TrkC antibody market will reach $2.56B by 2029 at 12.2% CAGR, driven by precision medicine, neuro-oncology research, biomarker diagnostics, and antibody innovations.
Read More
The Hepatitis B Virus (HBV) Capsid Inhibitors market size is expected to reach $0.86 billion in 2029 at a CAGR of 13.5%, driven by growth in demand for combination therapies.
Read More